RxDoctor Payments Data

Delaney Hartman, PA

Physician Assistant · Avon, INNPI 1255093514

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.3% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,449, 5.2 times the $279 reported in 2022. Among physician assistant clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,568in general payments, 2019–2025

Across 158 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$496
  • Pfizer$310
  • Urogen Pharma, Inc.$224
  • Novartis$209
  • Accord Healthcare, Inc.$200
  • Johnson & Johnson$175
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$3,25891%
  • Education$3109%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,568 in reported general payments places this provider in the 90th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana →

Medicare billing

Part B allowed, 2024
$144,104
Medicare patients
331
Services billed
4,913

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron68$72,414
MyrbetriqMirabegron25$25,060
Estradiol39$2,975
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst48$1,229
Tamsulosin Hcl85$1,153
NitrofurantoinNitrofurantoin Macrocrystal16$409
Alfuzosin Hcl ErAlfuzosin Hcl17$408
Cephalexin72$401
WaterWater For Irrigation,sterile19$246
Ciprofloxacin Hcl45$230
Fluconazole18$156
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$98
Levofloxacin22$88
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$69

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$496$72,41468 claims
Astellas Pharma US IncMyrbetriq$28$25,06025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Avon

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →